7-(4-Chlorobutoxy)-3,4-dihydro-2(1H)-quinolinone

GTC-186

Pharmaceutical Intermediates

7-(4-Chlorobutoxy)-3,4-dihydro-2(1H)-quinolinone

CAS No.
120004-79-7
Catalogue ID
GTC-186

7-(4-Chlorobutoxy)-3,4-dihydro-2(1H)-quinolinone, CAS 120004-79-7. Source-derived identification, physical data and applications are provided for catalogue reference; request the current specification, COA and SDS for the required grade.

Catalogue aliases / related identifiers

7-(4-Chlorobutoxy)-3,4-dihydroquinolin-2(1H)-one; 3,4-Dihydro-7-(4-chlorobutoxy)-2(1H)-quinolinone; 7-(4-Chlorobutoxy)-1,2,3,4-tetrahydroquinolin-2-one; Aripiprazole intermediate; Chlorobutoxy dihydroquinolinone

Supplied catalogue source: GTC-186 · Page 98

Reference data — confirm before ordering or use

The information below is a structured migration from the supplied catalogue snapshot. It is not a current product specification, COA or SDS. Confirm the actual supplier, grade, batch documents, classification, packing and destination requirements for your enquiry.


Basic Information

CAS No.120004-79-7
EC No.Not available
Linear FormulaC13H16ClNO2
Molecular Weight253.72
AppearanceWhite to off-white crystalline powder
Melting Point100-102 °C (lit.)
Boiling point449 °C (lit.)
Density1.19 g/mL (lit.)
SolubilitySoluble in organic solvents such as DMSO, methanol, and dichloromethane; limited solubility in water
Storage ConditionsKeep in a tightly closed container, protected from light, at 2-8 °C
Chemical StructureMolecular Structure of 7-(4-Chlorobutoxy)-3,4-dihydro-2(1H)-quinolinone

Key Applications

  • Pharmaceutical intermediate: A primary building block in the multi-step synthesis of aripiprazole, an atypical antipsychotic API, and an important component within Aripiprazole and Fluvoxamine intermediates for CNS-focused pharmaceutical development.

  • API intermediate: Enables efficient introduction of the chlorobutoxy side chain required for pharmacologically active quinolinone derivatives, especially in the preparation of CNS drug intermediates for antipsychotic synthesis.

  • Heterocyclic synthesis: Serves as a functionalized dihydroquinolinone scaffold for constructing nitrogen-containing heterocyclic molecules in pharmaceutical and fine chemical synthesis.

  • Medicinal chemistry research: Widely applied in laboratory route scouting and analog preparation within CNS drug discovery and process evaluation programs.

  • Process development: Supports scale-up and optimization studies for commercial manufacture of high-purity pharmaceutical intermediates for API synthesis.


  • Consistent product quality: Batch-to-batch consistency verified through routine analytical controls, meeting requirements for pharmaceutical intermediate applications.

  • Stable global supply: Reliable logistics network ensures timely delivery for laboratory, pilot, and commercial scale orders worldwide.

  • SDS and COA support: Comprehensive documentation including SDS and COA provided upon request to facilitate regulatory compliance and quality review.

  • Packaging and technical service: Flexible options such as 1 kg, 5 kg, or 25 kg fiber drums with PE liner, backed by responsive technical communication.

Before you order

Confirm the current commercial product record.

Include the required grade or purity, quantity, preferred packing, destination country/port and required document set.

  • 01Current specification
  • 02Batch or sample COA
  • 03Product- and supplier-specific SDS
  • 04Packing and shipping review
Request product review

INQUIRY

INQUIRY